Teladoc Health (NYSE: TDOC) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.34) by 55.88 percent. This is a 8.16 percent decrease over losses of $(0.49) per share from the same period last year. The company reported quarterly sales of $629.40 million which beat the analyst consensus estimate of $619.29 million by 1.63 percent. This is a 2.59 percent decrease over sales of $646.13 million the same period last year.